PPRC1是一种预后生物标志物,也是多发性骨髓瘤中线粒体氧化酸化的关键调节者

Yilin Liu1, Siqi Yan1, Xuemei Shu1

  • 1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Annals of medicine
|March 12, 2026
PubMed
概括

在多发性骨髓瘤 (MM) 中,氧酶增殖器激活受体玛联合激活器相关蛋白1 (PPRC1) 升高,表明存活率差. 向PPRC1可能为MM患者提供新的治疗策略.